课题基金 / 基金详情

Developing Targeted Therapies for Rare and Common Forms of Inflammatory Bowel Disease

Developing Targeted Therapies for Rare and Common Forms of Inflammatory Bowel Disease
开发针对罕见和常见炎症性肠病的靶向疗法
批准号:
389534
负责人:
Muise Aleixo M
金额:
$215.31万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
未结题
起止时间:
2018-09-01 至 2025-09-01

项目摘要

项目成果

Muise Aleixo M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Inflammatory Bowel Disease (IBD) is a common chronic illness of the gastrointestinal tract, which is predicted to affect nearly 1 in 100 Canadians by 2030. Children make up the most rapidly increasing group of patients with IBD and they may have severe di
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the immune dysregulation underlying Pediatric IBD to better diagnose and treat patients.
  • 批准号:
    411417
  • 项目类别:
    Operating Grants
  • 资助金额:
    $110.33万
  • 财政年份:
    2019
  • 负责人:
    Muise Aleixo M
  • 依托单位:
Defining the immuno-dysregulation underlying Pediatric IBD to better diagnose and treat patients.
  • 批准号:
    395677
  • 项目类别:
    Operating Grants
  • 资助金额:
    $1.46万
  • 财政年份:
    2018
  • 负责人:
    Muise Aleixo M
  • 依托单位:
Canada Research Chair - Tier 1
  • 批准号:
    404347
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2018
  • 负责人:
    Muise Aleixo M
  • 依托单位:
Defining Novel Therapies for Inflammatory Bowel Disease
  • 批准号:
    368062
  • 项目类别:
    Operating Grants
  • 资助金额:
    $62.98万
  • 财政年份:
    2017
  • 负责人:
    Muise Aleixo M
  • 依托单位:
国内基金
海外基金
Journal of Genetics and Genomics